NOX 0.00% 6.0¢ noxopharm limited

markets asleep... Two independent laboratories separately...

  1. 1,506 Posts.
    lightbulb Created with Sketch. 52
    markets asleep...


    Two independent laboratories separately confirm the effect in different cancer types

    Pre-clinical data indicates that idronoxil (active ingredient in Veyonda® ) achieves major goal in converting immunologically ‘COLD’ tumours to ‘HOT’

    COLD’ to ‘HOT’ conversion restores cancer-fighting immune cells to tumours, seen as a prerequisite in expanding the annual US$20 billion immuno-oncology drug market

    Noxopharm to commence discussions with global oncology firms
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
0.000(0.00%)
Mkt cap ! $17.53M
Open High Low Value Volume
6.1¢ 6.4¢ 6.0¢ $21.69K 353.0K

Buyers (Bids)

No. Vol. Price($)
6 294695 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 150000 1
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
6.2¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
6.1¢ 6.2¢ 6.0¢ 56127
Last updated 14.01pm 03/05/2024 ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.